CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 135 enrolled
Drug / intervention
fetal fibronectin measurementother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02694198
NCT02694198N/ACompleted

Fetal Fibronectin as a Predictor of Successful Induction of Mid-trimester Abortion

Ain Shams Maternity Hospital·observational·Posted Feb 29, 2016·Updated May 16, 2016

In Brief

An observational study evaluating fetal fibronectin measurement for Medical; Abortion, Fetus. Completed, enrolled 135 participants across 1 site.

Detailed Summary

Fetal Fibronectin as a Predictor of Successful Induction of Mid-trimester abortion.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesEgypt
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedFeb 29, 2016
Enrollment StartSep 1, 2015
Primary CompletionMar 1, 2016
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 10.3 years ago

Interventions

fetal fibronectin measurementother

All patients will be put in the dorsal lithotomy position.Using a proper light source and sterile gloves, a sterile speculum free of lubricants will be placed into the vagina before vaginal examination by senior resident and the special Dacron swab from the FFN kit will be used to collect a sample of secretions from the posterior fornix. The sample should be obtained prior to collection of any vaginal wet preparations, before any cervical manipulation or cervical cultures, and if enough amount of fluid (about 2 ml) is not found, vagina will be washed with 2 ml of normal saline.The swab will be placed in sterile plastic containers which will be stored until assayed quantitatively with an Enzyme-Linked Immuno Sorbant Assay.